CORESTEMCHEMON Inc. (KOSDAQ:166480)
South Korea · Delayed Price · Currency is KRW 3,500.00
-245.00 (-6.54%)
At close: May 15, 2026
CORESTEMCHEMON Market Cap
CORESTEMCHEMON has a market cap or net worth of 166.13 billion as of May 15, 2026. Its market cap has increased by 102.97% in one year.
Market Cap
166.13B
Enterprise Value
196.89B
Revenue
20.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,500.00
Market Cap Chart
Since June 26, 2015, CORESTEMCHEMON's market cap has decreased from 653.85B to 166.13B, a decrease of -74.59%. That is a compound annual growth rate of -11.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 155.26B | 89.39% |
| Dec 30, 2025 | 81.98B | -13.27% |
| Dec 30, 2024 | 94.52B | -34.79% |
| Dec 28, 2023 | 144.95B | -43.25% |
| Dec 29, 2022 | 255.40B | -13.00% |
| Dec 30, 2021 | 293.58B | -19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ViGenCell | 245.99B |
| Ensol Biosciences | 176.10B |
| ISU Abxis | 168.58B |
| QuadMedicine | 131.13B |
| Cell Biotech | 117.78B |
| BIO-FD&C | 113.48B |
| NovMetaPharma | 112.36B |
| CHA Vaccine Research Institute | 99.67B |